Integrated Filing — IndAS



General information about company

Scrip Code 544339
NSE Symbol LAXMIDENTL
MSEI Symbol NOTLISTED
ISIN INE0WO601020
Name of company LAXMI DENTAL LIMITED
Type of company Main Board
Class of security Equity
Date of start of financial year 01-04-2025
Date of end of financial year 31-03-2026
Date of board meeting when results were approved 21-05-2026
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 18-05-2026
Description of presentation currency INR
Level of rounding used in financial results Lakhs
Reporting Type Quarterly
Reporting Quarter Fourth quarter
Nature of report standalone or consolidated Consolidated
Whether results are audited or unaudited for the quarter ended Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Segment Reporting Multi segment
Description of single segment
Start date and time of board meeting 21-05-2026   16:00:00
End date and time of board meeting 21-05-2026   19:55:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion



Financial Results Ind-AS

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-01-2026 01-04-2025
B Date of end of reporting period 31-03-2026 31-03-2026
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Consolidated Consolidated
1 Income
Revenue from operations 7,395.50 27,785.80
Other income 236.00 854.60
Total income 7,631.50 28,640.40
2 Expenses
(a) Cost of materials consumed 1,180.50 2,509.60
(b) Purchases of stock-in-trade 1,292.80 5,755.90
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade (290.60) (46.80)
(d) Employee benefit expense 2,675.90 10,210.20
(e) Finance costs 34.50 136.60
(f) Depreciation, depletion and amortisation expense 438.20 1,587.50
(f) Other Expenses
1 Other Expenses 1,186.60 5,016.90
Total other expenses 1,186.60 5,016.90
Total expenses 6,517.90 25,169.90
3 Total profit before exceptional items and tax 1,113.60 3,470.50
4 Exceptional items 0.00 (577.90)
5 Total profit before tax 1,113.60 2,892.60
6 Tax expense
7 Current tax 44.90 660.20
8 Deferred tax 5.10 (410.60)
9 Total tax expenses 50.00 249.60
10 Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement 0.00 0.00
11 Net Profit Loss for the period from continuing operations 1,063.60 2,643.00
12 Profit (loss) from discontinued operations before tax 0.00 0.00
13 Tax expense of discontinued operations 0.00 0.00
14 Net profit (loss) from discontinued operation after tax 0.00 0.00
15 Share of profit (loss) of associates and joint ventures accounted for using equity method (54.10) 248.70
16 Total profit (loss) for period 1,009.50 2,891.70
17 Other comprehensive income net of taxes 127.20 143.30
18 Total Comprehensive Income for the period 1,136.70 3,035.00
19 Total profit or loss, attributable to
Profit or loss, attributable to owners of parent 1,008.10 2,897.90
Total profit or loss, attributable to non-controlling interests 1.50 (6.10)
20 Total Comprehensive income for the period attributable to
Comprehensive income for the period attributable to owners of parent 127.10 143.30
Total comprehensive income for the period attributable to owners of parent non-controlling interests 0.00 0.00
21 Details of equity share capital
Paid-up equity share capital 1,099.20 1,099.20
Face value of equity share capital 2 2
27 Details of debt securities
22 Reserves excluding revaluation reserve 23,232.80
23 Earnings per share
i Earnings per equity share for continuing operations
Basic earnings (loss) per share from continuing operations 1.83 5.53
Diluted earnings (loss) per share from continuing operations 1.83 5.53
ii Earnings per equity share for discontinued operations
Basic earnings (loss) per share from discontinued operations 0 0
Diluted earnings (loss) per share from discontinued operations 0 0
ii Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 1.83 5.53
Diluted earnings (loss) per share from continuing and discontinued operations 1.83 5.53
24 Debt equity ratio 0 0
25 Debt service coverage ratio 0 0
26 Interest service coverage ratio 0 0
27 Disclosure of notes on financial results Textual Information(1)



Disclosure of notes on financial results

Textual Information(1) Notes to the Consolidated Audited Financial Results: 1 The consolidated audited financial results of the Company for the year ended 31 March 2026 have been prepared in accordance with the Indian Accounting Standards (“Ind AS”) prescribed under Section 133 of the Companies Act, 2013 read with the relevant rules issued thereunder and other accounting principles generally accepted in India and in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. The aforesaid consolidated results were reviewed by the Audit Committee and approved by the Board of Directors at their respective meetings held on 21 May 2026. The Statutory Auditors of the Company have carried out an audit of the above results and have expressed an unmodified opinion on the aforesaid consolidated financial results. 2 The figures for the quarter ended 31 March 2026 and 31 March 2025 are the balancing figures between audited figures in respect of the full financial year and the published year-to-date figures up to the third quarter of the respective financial years. 3 Consolidated Segment wise Revenue, Results, Assets and Liabilities. The Chief Operational Decision Maker (CODM) monitors the operating results of its Business Segments separately for the purpose of making decisions about resource allocation and performance assessment. Segment performance is evaluated based on profit or loss and is measured consistently with profit or loss in the consolidated financial results. Operating segments have been identified on the basis of the nature of products / services and have been identified as per the quantitative criteria specified in the Ind AS 108 which are described below:- Laboratory Business : This segment comprises dental prosthetic products including metal-free crowns and bridges, Porcelain Fused to Metal (PFM) crowns and bridges, dentures and related dental laboratory equipment's such as scanners and related computer systems. Aligners Business : This segment comprises of Dental Aligners, Retainers, Raw Materials for Aligners, Sport Guards, Night Guards, Sleep Apnea Devices. Other Business : This segment comprises of Dental distribution products used in Dental Laboratory, Dental Clinical Services and Dental Educational Courses. Particulars Quarter ended Year Ended 31-Mar-26 31-Dec-25 31-Mar-25 31-Mar-26 31-Mar-25 Audited Unaudited Unaudited Audited Audited Segment revenue (Including inter-segment revenue) Laboratory business 544.79 478.27 384.44 1,968.72 1,541.62 Aligners business 189.08 186.52 192.18 766.52 808.51 Other business 17.28 18.77 47.37 86.41 149.45 Total 751.15 683.56 623.99 2,821.65 2,499.58 Less: Inter-segment revenue (11.61) (23.16) (17.31) (43.07) (108.51) Total revenue from operations 739.54 660.40 606.68 2,778.58 2,391.07 Segment results Laboratory business 72.30 54.27 83.25 301.90 262.22 Aligners business 62.31 20.64 14.35 144.37 149.20 Other business 0.41 (5.26) (2.36) (12.27) 7.31 - Total 135.02 69.65 95.24 434.00 418.73 Add: Other income 23.60 20.77 16.31 85.46 33.38 Less: Depreciation and amortisation (43.82) (41.70) (42.98) (158.75) (150.19) Less: Finance costs (3.45) (3.21) (12.57) (13.66) (53.90) Profit before exceptional item and tax 111.35 45.51 56.00 347.05 248.02 Exceptional item (refer note 6) - (57.79) 4.10 (57.79) 70.27 Profit/(loss) before tax 111.35 (12.28) 60.10 289.26 318.29 Less: Tax expense/(credit) (5.00) 21.56 (24.78) (24.96) (64.54) Add: Share in profit after tax of joint ventures (net) (5.41) 10.31 7.43 24.87 71.68 Net profit for the period/year from continuing operations 100.94 19.59 42.75 289.17 325.43 Loss after tax from discontinued operations - - - - (7.09) Profit for the period/ year 100.94 19.59 42.75 289.17 318.34 Segment assets and liabilities: The CODM does not monitor operating assets used by the operating segment. Therefore, disclosures of segment assets, liabilities and capital expenditure have not been given. 4 On 7 May 2024, the Company sold one of its investment properties for a total sale consideration of INR 101 million. The book value of the said property as on the date of sale was INR 7.10 million. Accordingly, the Company recognized a gain on sale of investment property amounting to INR 93.90 million. The tax expense arising from the transaction was initially computed at INR 27.73 million, and the net gain (after tax) of INR 66.17 million was disclosed as an exceptional gain in the financial statements for the period ended 31 December 2024. During the year ended 31 March 2025, the Company opted to avail the benefit under Section 115BAA of the Income-tax Act, 1961, which resulted in a change in the applicable tax rate. Consequently, the net tax effect on the aforesaid transaction was revised to INR 23.64 million, and the net exceptional gain has been recomputed to INR 70.27 million in these financial statements to reflect the impact of the revised tax rate. 5 Effective 21 November 2025, the Government of India consolidated 29 existing labour regulations into four Labour codes, namely, The Code on Wages, 2019, The Industrial Relations Code, 2020, The Code on Social Security, 2020 and the Occupational Safety, Health and Working Conditions Code, 2020, collectively referred to as the 'New Labour Codes'. The New Labour Codes has resulted in material increase in provision for gratuity expenses on account of recognition of past service costs. Based on the requirements of New Labour Codes and relevant Accounting Standard, the Group has assessed and accounted the estimated incremental impact of INR 57.79 millions as an Exceptional Item in the consolidated audited statement of financial results for the quarter and year ended 31 March 2026. Upon notification of the related Rules to the New Labour Codes by the Government and any further clarification from the Government on other aspects of the New Labour Codes, the Company will evaluate and account for additional impact if any, in subsequent periods. 6 During the year ended 31 March 2026, the holding company has invested in IDBG AI Dent Global Private Limited (IDBG AIDGPL), resulting in acquistion of 11,175 equity shares of face value INR 10 each at a premium of INR 1,217.50 per share (49% of the total equity shares), for an aggregate consideration of INR 13.72 million. The holding company has also subscirbed to 5,123 Compulsory Convertible Preference Shares (CCPS) of IDBG AIDGPL, without voting rights, of face value INR 10 each at a premium of INR 1,217.50 per CCPS, for an aggregate consideration of INR 6.29 million. 7 The utilisation of the proceeds of initial public offer (IPO) as on 31 March 2026 is summarised as below: (INR in millions) Particulars Objects of the issue (as per offer document) Utilised upto 31-Mar-2026 Unutilised as on 31-Mar-2026 Repayment/prepayment, in full or in part, of certain outstanding borrowings availed by our company 229.84 229.84 - Investment in certain Subsidiaries for the repayment/ prepayment, in full or in part, of certain outstanding borrowings 46.00 46.00 - Funding of capital expenditure requirements for purchase of new machinery for our Company 435.07 135.02 300.05 Investments in our Subsidiary, Bizdent Devices Private Limited, for the capital expenditure requirements for the purchase of new machinery 250.04 3.46 246.58 General Corporate purposes 320.75 320.75 - Total utilisation of funds 1,281.70 735.07 546.63 Out of the net proceeds which were unutilised as at 31 March 2026, INR 546.63 million are temporarily invested in fixed deposits. The Company is in the process of obtaining an extension for the utilization of the IPO proceeds in the subsequent period. 8 During the year ended 31 March 2026, the Group, pursuant to a strategic decision, discontinued the business operations of Rich Smile Design LLP. Accordingly, the financial results pertaining to the said entity have been disclosed as discontinued operations in accordance with the applicable provisions of Ind AS 105 – ‘Non-current Assets Held for Sale and Discontinued Operations’. 9 During the year ended 31 March 2026, the Board of Directors approved the Scheme of Merger of Bizdent Devices Private Limited, a wholly owned subsidiary, with the Holding Company, Laxmi Dental Limited. The Scheme provides for merger to be effective from 1 April 2026, subject to receipt of requisite statutory and regulatory approvals. As the Scheme is currently awaiting approval from the appropriate authorities, no effect of the proposed merger has been given in these consolidated financial results. 10 Previous period/year figures have been regrouped/reclassified, wherever necessary, to confirm to current period classification. 11 The consolidated financial results of the holding Company are available on the Company's website (www.laxmidentallimited.com) and stock exchanges websites, BSE (www.bseindia.com) and NSE (www.nseindia.com), where the shares of the Company are listed.



Remarks

Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio


Statement of Asset and Liabilities

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-04-2025
Date of end of reporting period 31-03-2026
Whether results are audited or unaudited Audited
Nature of report standalone or consolidated Consolidated
Assets
1 Non-current assets
Property, plant and equipment 5,924.30
Capital work-in-progress 0.00
Investment property 0.00
Goodwill 0.00
Other intangible assets 343.20
Intangible assets under development 0.00
Biological assets other than bearer plants 0.00
Investments accounted for using equity method 1,457.20
Non-current financial assets
Non-current investments 0.00
Trade receivables, non-current 0.00
Loans, non-current 0.00
Other non-current financial assets
1 Other non-current financial assets 1,362.60
Total of other non-current financial assets 1,362.60
Total non-current financial assets 1,362.60
Deferred tax assets (net) 1,037.20
Other non-current assets
1 Other non-current assets 137.50
Total of other non-current assets 137.50
Total non-current assets 10,262.00
2 Current assets
Inventories 2,175.30
Current financial asset
Current investments 1,269.50
Trade receivables, current 4,553.80
Cash and cash equivalents 839.90
Bank balance other than cash and cash equivalents 113.90
Loans, current 24.00
Other current financial assets
Total of other current financial assets 8,181.10
Total current financial assets 14,982.20
Current tax assets (net) 263.00
Other current assets
1 Other current assets 1,714.70
Total of other current assets 1,714.70
Total current assets 19,135.20
3 Non-current assets classified as held for sale 0.00
4 Regulatory deferral account debit balances and related deferred tax Assets 0.00
Total assets 29,397.20
Equity and liabilities
1 Equity
Equity attributable to owners of parent
Equity share capital 1,099.20
Other equity 23,232.80
Total equity attributable to owners of parent 24,332.00
Non controlling interest 79.20
Total equity 24,411.20
2 Liabilities
Non-current liabilities
Non-current financial liabilities
Borrowings, non-current 0.00
Trade payables, non-current
(A) Total outstanding dues of micro enterprises and small enterprises 0.00
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 0.00
Total Trade payable 0.00
Other non-current financial liabilities
1 Other non-current financial liabilities 69.10
Total of other non-current financial liabilities 69.10
Total non-current financial liabilities 69.10
Provisions, non-current 931.30
Deferred tax liabilities (net) 0.00
Deferred government grants, Non-current 0.00
Other non-current liabilities
1 Other non-current liabilities 906.50
Total of other non-current liabilities 906.50
Total non-current liabilities 1,906.90
Current liabilities
Current financial liabilities
Borrowings, current 0.00
Trade payables, current
(A) Total outstanding dues of micro enterprises and small enterprises 199.80
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 868.20
Total Trade payable 1,068.00
Other current financial liabilities
1 Other current financial liabilities 858.30
Total of other current financial liabilities 858.30
Total current financial liabilities 1,926.30
Other current liabilities 909.20
1 Other current liabilities 909.20
Total of other current liabilities 909.20
Provisions, current 243.60
Current tax liabilities (Net) 0.00
Deferred government grants, Current 0.00
Total current liabilities 3,079.10
3 Liabilities directly associated with assets in disposal group classified as held for sale 0.00
4 Regulatory deferral account credit balances and related deferred tax liability 0.00
Total liabilities 4,986.00
Total equity and liabilites 29,397.20
Disclosure of notes on assets and liabilities



Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Amount in (Lakhs)

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-01-2026 01-04-2025
Date of end of reporting period 31-03-2026 31-03-2026
Whether results are audited or unaudited Audited Audited
Nature of report standalone or consolidated Consolidated Consolidated
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
1 Laboratory Business 5,447.90 19,687.20
2 Aligners Business 1,890.80 7,665.20
3 Other business 0.001728 0.008641
Total Segment Revenue 7,511.50 28,216.50
Less: Inter segment revenue 116.10 430.70
Revenue from operations 7,395.40 27,785.80
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
1 Laboratory Business 723.00 3,019.00
2 Aligners Business 623.10 1,443.70
3 Other business 4.10 (122.70)
Total Profit before tax 1,350.20 4,340.00
i. Finance cost 34.50 136.60
ii. Other Unallocable Expenditure net off Unallocable income 202.20 1,310.80
Profit before tax 1,113.50 2,892.60
3 (Segment Asset - Segment Liabilities)
Segment Asset
1 Laboratory Business 0.00 0.00
2 Aligners Business 0.00 0.00
3 Other business 0.00 0.00
Total Segment Asset 0.00 0.00
Un-allocable Assets 0.00 0.00
Net Segment Asset 0.00 0.00
4 Segment Liabilities
Segment Liabilities
1 Laboratory Business 0.00 0.00
2 Aligners Business 0.00 0.00
3 Other business 0.00 0.00
Total Segment Liabilities 0.00 0.00
Un-allocable Liabilities 0.00 0.00
Net Segment Liabilities 0.00 0.00
Disclosure of notes on segments



Other Comprehensive Income

Amount in (Lakhs)

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-01-2026 01-04-2025
B Date of end of reporting period 31-03-2026 31-03-2026
C Whether results are audited or unaudited Audited Audited
D Nature of report standalone or consolidated Consolidated Consolidated
Other comprehensive income [Abstract]
1 Amount of items that will not be reclassified to profit and loss
1 Total Amount of items that will not be reclassified to profit and loss 70.10 10.50
Total Amount of items that will not be reclassified to profit and loss 70.10 10.50
2 Income tax relating to items that will not be reclassified to profit or loss 17.20 2.50
3 Amount of items that will be reclassified to profit and loss
Total Amount of items that will be reclassified to profit and loss
4 Income tax relating to items that will be reclassified to profit or loss (74.30) (135.30)
5 Total Other comprehensive income 127.20 143.30



Cash flow statement, indirect

Amount in (Lakhs)

Particulars Year ended (dd-mm-yyyy)
A Date of start of reporting period 01-04-2025
B Date of end of reporting period 31-03-2026
C Whether results are audited or unaudited Audited
D Nature of report standalone or consolidated Consolidated
Statement of cash flows
Cash flows from used in operating activities
Profit before tax 2,892.60
Adjustments for reconcile profit (loss)
Adjustments for finance costs 0.00
Adjustments for decrease (increase) in inventories (310.40)
Adjustments for decrease (increase) in trade receivables, current (828.70)
Adjustments for decrease (increase) in trade receivables, non-current 0.00
Adjustments for decrease (increase) in other current assets 0.00
Adjustments for decrease (increase) in other non-current assets (266.70)
Adjustments for other financial assets, non-current (1,085.20)
Adjustments for other financial assets, current 0.00
Adjustments for other bank balances 0.00
Adjustments for increase (decrease) in trade payables, current (2,059.70)
Adjustments for increase (decrease) in trade payables, non-current 0.00
Adjustments for increase (decrease) in other current liabilities 0.00
Adjustments for increase (decrease) in other non-current liabilities 126.60
Adjustments for depreciation and amortisation expense 1,587.50
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss (117.80)
Adjustments for provisions, current 0.00
Adjustments for provisions, non-current 0.00
Adjustments for other financial liabilities, current 0.00
Adjustments for other financial liabilities, non-current 169.60
Adjustments for unrealised foreign exchange losses gains (17.90)
Adjustments for dividend income 0.00
Adjustments for interest income 587.20
Adjustments for share-based payments 526.10
Adjustments for fair value losses (gains) (5.20)
Adjustments for undistributed profits of associates 0.00
Other adjustments for which cash effects are investing or financing cash flow 0.00
Other adjustments to reconcile profit (loss) 0.00
Other adjustments for non-cash items 8.20
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0.00
Total adjustments for reconcile profit (loss) (2,860.80)
Net cash flows from (used in) operations 31.80
Dividends received 0.00
Interest paid (136.60)
Interest received 0.00
Income taxes paid (refund) 668.20
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) operating activities (499.80)
Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 23.20
Cash flows used in obtaining control of subsidiaries or other businesses 0.00
Other cash receipts from sales of equity or debt instruments of other entities 0.00
Other cash payments to acquire equity or debt instruments of other entities 0.00
Other cash receipts from sales of interests in joint ventures 0.00
Other cash payments to acquire interests in joint ventures 0.00
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0.00
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 260.10
Proceeds from sales of property, plant and equipment 32.70
Purchase of property, plant and equipment 1,627.70
Proceeds from sales of investment property 0.00
Purchase of investment property 0.00
Proceeds from sales of intangible assets 0.00
Purchase of intangible assets 209.40
Proceeds from sales of intangible assets under development 0.00
Purchase of intangible assets under development 0.00
Proceeds from sales of goodwill 0.00
Purchase of goodwill 0.00
Proceeds from biological assets other than bearer plants 0.00
Purchase of biological assets other than bearer plants 0.00
Proceeds from government grants 0.00
Proceeds from sales of other long-term assets 0.00
Purchase of other long-term assets 0.00
Cash advances and loans made to other parties 0.00
Cash receipts from repayment of advances and loans made to other parties 0.00
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0.00
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0.00
Dividends received 0.00
Interest received 574.80
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash (6,491.90)
Net cash flows from (used in) investing activities (7,958.40)
Cash flows from used in financing activities
Proceeds from changes in ownership interests in subsidiaries 0.00
Payments from changes in ownership interests in subsidiaries 0.00
Proceeds from issuing shares 0.00
Proceeds from issuing other equity instruments 0.00
Payments to acquire or redeem entity's shares 0.00
Payments of other equity instruments 0.00
Proceeds from exercise of stock options 0.00
Proceeds from issuing debentures notes bonds etc 0.00
Proceeds from borrowings 0.00
Repayments of borrowings 1,136.80
Payments of lease liabilities 501.80
Dividends paid 0.00
Interest paid 136.60
Income taxes paid (refund) 0.00
Other inflows (outflows) of cash 0.00
Net cash flows from (used in) financing activities (1,775.20)
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes (10,233.40)
Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 137.20
Net increase (decrease) in cash and cash equivalents (10,096.20)
Cash and cash equivalents cash flow statement at beginning of period 10,936.00
Cash and cash equivalents cash flow statement at end of period 839.80





Details of Impact of Audit Qualification

Amount in (Lakhs)

Whether results are audited or unaudited Audited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 M S K A & Associates LLP Yes 31-07-2027